Fudan University Shanghai Cancer Center
Source: http://www.shca.org.cn/english
Archived: 2026-04-23 16:47
Fudan University Shanghai Cancer Center
微信
微博
HOME
ABOUT US
PATIENTS AND VISITORS
MEDICAL PROFESSIONALS
RESEARCH
CONTACT US
Notice Board
HISTORY
THE CENTER
SISTER INSTITUTION COOPERATIONS
NEWSROOM
PUBLICATIONS
MDT TEAMS
CLINICAL DEPARTMENTS
DIAGNOSTIC DEPARTMENTS
FIND DOCTORS
EDUCATION & TRAINING
CANCER INSTITUTE
SCI PAPER
GETTING TO FUSCC
A Multi-Cohort Analysis from "Fudan University Shanghai Cancer Center" Reveals Global Patterns in Genomic Mutations among Patients with Early-Onset Colorectal Cancer
Fudan University Team Led by Sheng Weiqi and Xu Midie Reports CCT6A Modulates Tumor Microenvironment via Intercellular Shuttling, Establishing a Pro-Tumor "Metabolic Niche"
Fudan University Shanghai Cancer Center Breakthrough Discovery: “Metabolic Waste” Offers New Hope for Immunotherapy in "King of Cancers"
Recently, the research team led by Professor Xianjun Yu and Doctor Si Shi from Fudan University Shanghai Cancer Center published a groundbreaking study revealing that lactate, traditionally regarded as a “metabolic waste,”
Nature | Xu Yanhui team uncovers the dynamics of RNA polymerase III transcription initiation
RNA polymerases (RNAPs) are the core enzymes of transcription, responsible for transcribing genetic information from DNA into RNA. In mammalian nuclei, RNAPs have evolved into three functionally distinct forms...
Voice of China at ESSO | FUSCC was invited to the international stage, showcasing the wisdom and elegance of Chinese colorectal oncologists
From October 2nd to 4th, 2024, the 43rd Congress of the European Society of Surgical Oncology (ESSO) was held in Antwerp, Belgium.
NEWS
-
The Self-Developed Human Pancreatic Cancer 6-Gene Detection Kit by Fudan University Shanghai Cancer Center Secures Filing Approval, Breaking the Dilemma of Precision Diagnosis and Treatment for the "King of Cancers"
-
Sensory Neurons Help Tumors Evade Immunotherapy in Triple-Negative Breast Cancer
-
'China solution' targets high-risk breast cancer
-
FUSCC’s TORCH‑E Study Published in Clinical Cancer Research: 72.7% Complete Response Rate in Early Low Rectal Cancer
Notice Board
-
WIN 2019
-
WIN 2018
-
MD Anderson Cancer Center - Tokyo Oncology Consortium / Sister Institution Memorial Symposium/Oncology Forum 2017
-
2017 SABR SYMPOSIUM
-
UICC and Pfizer announce the next phase of the global grants initiative supporting metastatic breast cancer patients
PUBLICATIONS
-
Pregnancy hope for cancer patients
-
Cancer patient delivers healthy baby
LINKS
微信
微博
HOME
ABOUT US
PATIENTS AND VISITORS
MEDICAL PROFESSIONALS
RESEARCH
CONTACT US
Notice Board
HISTORY
THE CENTER
SISTER INSTITUTION COOPERATIONS
NEWSROOM
PUBLICATIONS
MDT TEAMS
CLINICAL DEPARTMENTS
DIAGNOSTIC DEPARTMENTS
FIND DOCTORS
EDUCATION & TRAINING
CANCER INSTITUTE
SCI PAPER
GETTING TO FUSCC
A Multi-Cohort Analysis from "Fudan University Shanghai Cancer Center" Reveals Global Patterns in Genomic Mutations among Patients with Early-Onset Colorectal Cancer
Fudan University Team Led by Sheng Weiqi and Xu Midie Reports CCT6A Modulates Tumor Microenvironment via Intercellular Shuttling, Establishing a Pro-Tumor "Metabolic Niche"
Fudan University Shanghai Cancer Center Breakthrough Discovery: “Metabolic Waste” Offers New Hope for Immunotherapy in "King of Cancers"
Recently, the research team led by Professor Xianjun Yu and Doctor Si Shi from Fudan University Shanghai Cancer Center published a groundbreaking study revealing that lactate, traditionally regarded as a “metabolic waste,”
Nature | Xu Yanhui team uncovers the dynamics of RNA polymerase III transcription initiation
RNA polymerases (RNAPs) are the core enzymes of transcription, responsible for transcribing genetic information from DNA into RNA. In mammalian nuclei, RNAPs have evolved into three functionally distinct forms...
Voice of China at ESSO | FUSCC was invited to the international stage, showcasing the wisdom and elegance of Chinese colorectal oncologists
From October 2nd to 4th, 2024, the 43rd Congress of the European Society of Surgical Oncology (ESSO) was held in Antwerp, Belgium.
NEWS
-
The Self-Developed Human Pancreatic Cancer 6-Gene Detection Kit by Fudan University Shanghai Cancer Center Secures Filing Approval, Breaking the Dilemma of Precision Diagnosis and Treatment for the "King of Cancers"
-
Sensory Neurons Help Tumors Evade Immunotherapy in Triple-Negative Breast Cancer
-
'China solution' targets high-risk breast cancer
-
FUSCC’s TORCH‑E Study Published in Clinical Cancer Research: 72.7% Complete Response Rate in Early Low Rectal Cancer
Notice Board
-
WIN 2019
-
WIN 2018
-
MD Anderson Cancer Center - Tokyo Oncology Consortium / Sister Institution Memorial Symposium/Oncology Forum 2017
-
2017 SABR SYMPOSIUM
-
UICC and Pfizer announce the next phase of the global grants initiative supporting metastatic breast cancer patients
PUBLICATIONS
-
Pregnancy hope for cancer patients
-
Cancer patient delivers healthy baby
LINKS